Drug · DIN 02257904
ACT SUMATRIPTAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2021; first marketed August 24, 2005.
- Drug Identification Number (DIN)
- 02257904
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 23, 2020: NOC 23507Abbreviated New Drug Submission (ANDS) · Updated labelling materials. removal of discontiued strengths from the product monograph and merger-buyout
- May 28, 2014: NOC 15658Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- August 24, 2005: NOC 7315Abbreviated New Drug Submission (ANDS)
Other DINs named ACT SUMATRIPTAN
- DIN 02257882 · Cancelled Post Market
- DIN 02257890 · Cancelled Post Market